# FDA 483 - Arizona Associates for Reproductive Health - April 12, 2021

Source: https://www.globalkeysolutions.net/records/483/arizona-associates-for-reproductive-health/9801559f-36a9-483e-8511-0f953fadb953

> FDA 483 for Arizona Associates for Reproductive Health on April 12, 2021. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Arizona Associates for Reproductive Health
- Inspection Date: 2021-04-12
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Arizona Associates for Reproductive Health in Scottsdale, AZ, was cited for failing to adequately screen oocyte donors for communicable disease risk factors. Specifically, the firm did not document screening for Zika virus risk factors for multiple anonymous and directed oocyte donors. This lapse in screening raises concerns about donor eligibility and the safety of donated reproductive tissue.

## Related Officers

- [Garrad R. Poole](https://www.globalkeysolutions.net/people/garrad-r-poole/7fc97953-367e-459b-905d-25efe6ec39d2)

Company: https://www.globalkeysolutions.net/companies/arizona-associates-for-reproductive-health/94ac7dcb-0045-4823-a7dc-2b35a4b63d41

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6